Public Health & Preventive Health_Epidemiology Flashcards
How are patients in case control study grouped and evaluated?
- Persons with a known outcome, such as cancer, are identified as cases
- those without the outcome as controls.
- The study compares the groups, looking for multiple potential exposures of the outcome.
What primary measures?
- measures aimed at preventing the development of a disease, for example vaccines.
What are secondary prevention measures?
- measures aimed at detecting disease early, for example, colonoscopies, seek to detect early colon cancer.
What are tertiary prevention measures?
- measures aimed at reducing the negative impact of an already established disease, and reducing disease related complications.
- For example, monitoring for microalbuminuria seeks to identify and treat patients at risk for developing diabetic nephropathy.
Correlation study ___
- uses population data, such as comparing the country’s alcohol intake to its prevalence of coronary artery disease
case report is ________
a descriptive study of factors that could be related to an outcome.
cross sectional study assesses ___
the outcome and exposure simultaneously.
can cross sectional studies prove causality?
No, because the temporal relationship between the variables is unknown.
Give examples of the following analytic or hypothesis testing study designs.
- Observational
- cohort and case control study
- interventional
- randomized controlled trials.
How are patients in a cohort study grouped and evaluated?
- Participants are divided into groups based on some exposure, for example low versus high fat diets.
- The study compares multiple potential outcomes of the exposure.
What prospective studies?
- At the study initiation the disease has not occurred, and the study group is followed forward in time.
What retrospective studies?
- At study initiation diseases has occurred and the researcher looks back in time to identify potential etiologies or causes.
The percent of the population with a disease at a given point in time (# persons with the disease/# persons in the total population)
Prevalence
The percent of the population who develop a disease over a period of time (# persons who develop the disease/# persons who are initially disease-free in a population)
Incidence